This is not a trivial task because the amino acid RG7112 solubility dmso sequence of most effectors does not display significant similarity to proteins of known function. Additionally, BYL719 nmr T3S substrates, which should comprise the bulk of Chlamydia effectors, contain no easily recognizable secretion signal. Moreover, in spite of the recent development of systems for transformation of Chlamydia[17, 18], for a long

time no methods have been available for genetic manipulation of these bacteria. To overcome these obstacles, chlamydial effectors have been searched: i) by systematic phenotypic analyses of yeast Saccharomyces cerevisiae expressing individual chlamydial proteins [19]; ii) by using Salmonella[20], Shigella[15, 21–23], or Yersinia[13, 14, 24–27] as genetically tractable heterologous host bacteria carrying well characterized T3SSs; or iii) by complex computational predictions of T3S signals [28–30]. The subsequent use of specific antibodies enabled to detect translocation into host cells of some of the C. trachomatis proteins singled out in these searches, such as in the case of Tarp/CT456 [25], CT694 [14], CopN/CT089 [24], Cap1/CT529 [31], CT620 [22], CT621 [22, 32], CT711 [22], lipid-droplet associated (Lda) proteins Lda1/CT156,

Lda2/CT163, and Lda3/CT473 [33], Nue/CT737 [15], or of a group of proteins containing a hydrophobic motif thought to mediate their insertion into the inclusion membrane (Inc proteins) [12, 34]. Moreover, the

direct use of antibodies raised against particular C. trachomatis proteins (CT311, CT622, CT795, GlgA/CT798, HtrA/CT823, or Pgp3) revealed their presence PD 332991 in the host cell cytosol or nucleus of infected cells [35–40]. Finally, the in vitro deubiquitinase activity of ChlaDUB1/CT868 and of ChlaDUB2/CT867 [41], and Edoxaban the capacity of ChlaDUB1/CT868 to suppress the NF-κB pathway in transfected cells [42], indicate that these two proteins should be effectors. In this work, we have surveyed the genome of C. trachomatis mostly for genes encoding uncharacterized proteins that were not described before as T3S substrates. We then used Yersinia enterocolitica as a heterologous system to identify 10 novel likely T3S substrates of C. trachomatis and real-time quantitative PCR (RT-qPCR) to show that 9 of the genes encoding these proteins are clearly expressed during the bacterial developmental cycle. Furthermore, we showed that 7 of the 10 likely T3S substrates of C. trachomatis could be translocated into host cells by Y. enterocolitica. Therefore, we identified several novel putative effectors of C. trachomatis. Methods Cell culture, bacterial strains and growth conditions HeLa 229 (ATCC) cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM; Invitrogen) supplemented with 10% (v/v) foetal bovine serum (FBS; Invitrogen) at 37°C in a humidified atmosphere of 5% (v/v) CO2. C.